References
- Mathus-Vliegen EM, Eichenberger RI. Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg. 2014;24(1):85–94.
- Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1(8265):198–199.
- Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology. 1990;99(2):362–369.
- Benjamin SB. Small bowel obstruction and the Garren-Edwards gastric bubble: an iatrogenic bezoar. Gastrointest Endosc. 1988;34(6):463–467.
- Ulicny KS, Jr., Goldberg SJ, Harper WJ, et al. Surgical complications of the Garren-Edwards Gastric Bubble. Surg Gynecol Obstet. 1988;166(6):535–540.
- Mathus-Vliegen EM, Tytgat GN. Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg. 1990;77(1):76–79.
- Hogan RB, Johnston JH, Long BW, et al. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity. Gastrointest Endosc. 1989;35(5):381–385.
- Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19. Gastrointest Endosc. 1987;33(4):323–327. 21, 1987.
- De Castro ML, Morales MJ, Del Campo V, et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg. 2010;20(12):1642–1646.
- Kissileff HR, Carretta JC, Geliebter A, et al. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol. 2003;285(5):R992–8.
- Mion F, Napoleon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15(4):510–516.
- Su HJ, Kao CH, Chen WC, et al. Effect of intragastric balloon on gastric emptying time in humans for weight control. Clin Nucl Med. 2013;38:863–868.
- Gomez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study. Obesity (Silver Spring)). 2016;24(9):1849–1853.
- Zerrweck C, Maunoury V, Caiazzo R, et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg. 2012;22(5):777–782.
- Bazerbachi F, Vargas EJ, Rizk M, et al. Intragastric balloon placement induces significant metabolic and histologic improvement in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2021;19(1):146–154.e4. doi: https://doi.org/10.1016/j.cgh.2020.04.068.
- Neto MG, Silva LB, Grecco E, et al. Brazilian intragastric balloon consensus statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis. 2018;14(2):151–159.
- Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14(7):991–998.
- Lopez-Nava G, Jaruvongvanich V, Storm AC, et al. Personalization of endoscopic bariatric and metabolic therapies based on physiology: a prospective feasibility study with a single fluid-filled intragastric balloon. OBES Surg. 2020;30(9):3347–3353. [e-pub ahead of print 2020/04/15].
- Courcoulas A, Abu Dayyeh BK, Eaton L, et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes. 2017;41(3):427–433.
- Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects - Study Results [Internet]. Study Results - ClinicalTrials.gov. [cited 2020. May11]. Available from: https://clinicaltrials.gov/ct2/show/results/NCT00730327.
- Machytka E, Kz Awadhi S, Falasi M, et al. First reports of the new Spatz 3 adjustable ballon system. United Eur Gastroent. 2014;2(Supplement 1): A132–A605. doi: https://doi.org/10.1177/2050640614548980.
- Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011;21(10):1499–1507.
- Genco A, Dellepiane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy. Obes Surg. 2013;23(7):953–958.
- Machytka E, Brooks J, Buzga M, et al. One year adjustable intragastric balloon: safety and efficacy of the Spatz3 adjustable balloons. F1000Res. 2014;3:203.
- Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014;24(5):813–819.
- Machytka E, Marinos G, Kerdahi RF, et al. Tu1467 Spatz adjustable balloons: results of adjustment for intolerance and for weight loss plateau. Gastroenterology. 2015;148(4):S-900.
- Lecumberri E, Krekshi W, Matia P, et al. Effectiveness and safety of air-filled balloon Heliosphere BAG(R) in 82 consecutive obese patients. Obes Surg. 2011;21(10):1508–1512.
- Hegade VS, Sood R, Douds AC. Small bowel obstruction induced by spontaneous partial deflation of an intragastric balloon. Ann R Coll Surg Engl. 2012;94(4):e171–e173.
- Moszkowicz D, Lefevre JH. Deflated intragastric balloon-induced small bowel obstruction. Clin Res Hepatol Gastroenterol. 2012;36(1):e17–e19.
- Giardiello C, Borrelli A, Silvestri E, et al. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obes Surg. 2012;22(12):1916–1919.
- Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11(4):874–881.
- Vantanasiri K, Matar R, Beran A, et al. The efficacy and safety of a procedureless gastric balloon for weight loss: a systematic review and meta-analysis. OBES Surg. 2020;30(9):3341–3346. [e-pub ahead of print 2020/04/09].
- Ienca R, Al Jarallah M, Caballero A, et al. The procedureless elipse gastric balloon program: multicenter experience in 1770 consecutive patients. OBES Surg. 2020;30(11):4691–4692. [e-pub ahead of print 2020/04/13].
- Moore RL, Seger MV, Garber SM, et al. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization. Surg Obes Relat Dis. 2019;15(3):417–423.
- Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al.; ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–438 e5.
- Kumar N, Bazerbachi F, Rustagi T, et al. The influence of the orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg. 2017;27(9):2272–2278.
- Sander B, Neto MG, Fittipaldi-Fernandez R, et al. Intragastric balloon: A Brazilian multicentric study of 3545 cases. Surg Obes Relat Dis. 2015;11(6):S3.
- Gumurdulu Y, Dogan UB, Akin MS, et al. Long-term effectiveness of BioEnterics intragastric balloon in obese patients. Turk J Gastroenterol. 2013;24(5):387–391.
- Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc. 2010;71(6):927–933.
- Deliopoulou K, Konsta A, Penna S, et al. The impact of weight loss on depression status in obese individuals subjected to intragastric balloon treatment. Obes Surg. 2013;23(5):669–675.
- Wojciechowska-Kulik A, Blus E, Kowalczyk Z, et al. The effect of noninvasive bariatric surgery on the levels of certain adipokines and atherosclerosis risk factors in patients with metabolic syndrome. J Am Coll Nutr. 2020;39(6):481–487. doi: https://doi.org/10.1080/07315724.2019.1695017.
- Guedes MR, Fittipaldi-Fernandez RJ, Diestel CF, et al. Impact of intragastric balloon treatment on adipokines, cytokines, and metabolic profile in obese individuals. Obes Surg. 2019;29(8):2600–2608.
- Salomone F, Sharaiha RZ, Boskoski I. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. Liver Int. 2020;40(6):1262–1268.
- Popov VB, Thompson CC, Kumar N, et al. Effect of intragastric balloons on liver enzymes: a systematic review and meta-analysis. Dig Dis Sci. 2016;61(9):2477–2487.
- Ubeda-Iglesias A, Irles-Rocamora JA, Povis-López CD. [Antral impaction and cardiorespiratory arrest. Complications of the intragastric balloon]. Med Intensiva. 2012;36(4):315–317.
- de Quadros LG, Dos Passos Galvão Neto M, Grecco E, et al. Intragastric balloon hyperinsufflation as a cause of acute obstructive abdomen. ACG Case Rep J. 2018;5:e69.
- Matar ZS, Mohamed AA, Abukhater M, et al. Small bowel obstruction due to air-filled intragastric balloon. Obes Surg. 2009;19(12):1727–1730.
- Vanden Eynden F, Urbain P. Small intestine gastric balloon impaction treated by laparoscopic surgery. Obes Surg. 2001;11(5):646–648.
- Francica G, Giardiello C, Iodice G, et al. Ultrasound as the imaging method of choice for monitoring the intragastric balloon in obese patients: normal findings, pitfalls and diagnosis of complications. Obes Surg. 2004;14(6):833–837.
- Koutelidakis I, Dragoumis D, Papaziogas B, et al. Gastric perforation and death after the insertion of an intragastric balloon. Obes Surg. 2009;19(3):393–396.
- Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15(8):1161–1164.
- Giardiello C, Cristiano S, Cerbone MR, et al. Gastric perforation in an obese patient with an intragastric balloon, following previous fundoplication. Obes Surg. 2003;13(4):658–660.
- Sanchez-Perez MA, Munoz-Juarez M, Cordera-Gonzalez de Cosio F, et al. Gastric perforation and subarachnoid hemorrhage secondary to intragastric balloon device. Rev Gastroenterol Mex. 2011;76:264–269.
- Aljiffry M, Habib R, Kotbi E, et al. Acute pancreatitis: a complication of intragastric balloon. Surg Laparosc Endosc Percutan Tech. 2017;27(6):456–459.